As of May 14, 2026, CG Oncology's top three insider holders are Hong Fang Song (Director, 5.84Mn shares), Hong Fang Song (Director, 5.84Mn shares), Hong Fang Song (Director, 5.84Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Hong Fang Song | - | 0 | 5,838,167 | 04 Sep, 2025 |
| Hong Fang Song | - | 0 | 5,838,167 | 04 Sep, 2025 |
| Hong Fang Song | - | 0 | 5,838,167 | 04 Sep, 2025 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 4,958,810 | 0 | 09 Apr, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 4,958,810 | 0 | 09 Apr, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 4,958,810 | 0 | 09 Apr, 2024 |
| Brian Guan-Chyun Liu | - | 0 | 1,515,151 | 12 Sep, 2025 |
| Brian Guan-Chyun Liu | - | 0 | 1,515,151 | 12 Sep, 2025 |
| Brian Guan-Chyun Liu | - | 0 | 1,515,151 | 12 Sep, 2025 |
| Hong Fang Song | - | 613,928 | 0 | 31 Jan, 2024 |
| Hong Fang Song | - | 613,928 | 0 | 31 Jan, 2024 |
| Hong Fang Song | - | 613,928 | 0 | 31 Jan, 2024 |
| Hong Fang Song | - | 0 | 586,982 | 30 Aug, 2024 |
| Hong Fang Song | - | 0 | 586,982 | 30 Aug, 2024 |
| Hong Fang Song | - | 0 | 586,982 | 30 Aug, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 0 | 400,000 | 31 Jan, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 0 | 400,000 | 31 Jan, 2024 |
| Capital Global Life Sciences Fund Iv, L.P. Decheng | - | 0 | 400,000 | 31 Jan, 2024 |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Arthur Kuan | Chief Executive Officer | 198,916 | 0 | 13 Mar, 2026 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Corleen M. Roche | Cfo Secretary | 2,000 | 0 | 31 Jan, 2024 |
| Vijay Kasturi | Chief Medical Officer | 1,315 | 0 | 31 Jan, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Apr, 2026 | James Mulay | Common Stock | A | 15,600 | $36.63 | 15,600 | D | M |
| 17 Apr, 2026 | James Mulay | Common Stock | D | 15,600 | $73.01 | 0 | D | S |
| 17 Apr, 2026 | James Mulay | Director Stock Option (right to buy) | D | 15,600 | $0.00 | 0 | D | M |
| 15 Apr, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | A | 271,600 | $0.00 | 271,600 | D | A |
| 15 Apr, 2026 | Vijay Kasturi | Employee Stock Option (Right to Buy) | A | 79,216 | $0.00 | 79,216 | D | A |
| 15 Apr, 2026 | Joshua F. Patterson | Employee Stock Option (Right to Buy) | A | 45,266 | $0.00 | 45,266 | D | A |
| 15 Apr, 2026 | Arthur Kuan | Employee Stock Option (Right to Buy) | A | 271,600 | $0.00 | 271,600 | D | A |
| 15 Apr, 2026 | Ambaw Bellete | Employee Stock Option (Right to Buy) | A | 107,508 | $0.00 | 107,508 | D | A |
| 15 Apr, 2026 | James M. Detore | Employee Stock Option (Right to Buy) | A | 90,574 | $0.00 | 90,574 | D | A |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 654 | $3.72 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 654 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Common Stock | A | 1,310 | $12.59 | 1,310 | D | M |
| 16 Mar, 2026 | James Mulay | Common Stock | D | 1,310 | $63.50 | 0 | D | S |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 654 | $0.00 | 654 | D | M |
| 16 Mar, 2026 | James Mulay | Director Stock Option (right to buy) | D | 1,310 | $0.00 | 3,930 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | A | 64,612 | $1.72 | 200,763 | D | M |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | D | 1,847 | $60.15 | 198,916 | D | F |
| 12 Mar, 2026 | Arthur Kuan | Common Stock | D | 1,847 | $60.15 | 198,916 | D | F |